
Cognito Therapeutics
Developing a novel therapeutic approach for Alzheimer's disease.
About
Cognito Therapeutics is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic approach for Alzheimer's disease. Their lead product candidate, Spectris™, is a non-invasive, wearable neurostimulation device designed to treat cognitive decline associated with Alzheimer's. The company aims to address the underlying pathology of the disease by modulating brain activity.
Listed competitors
Also in this space
Global network of clinics using AI and data science to treat age-related cognitive and functional decline.
Shares Healthcare
FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.
In MedTech
AI-powered platform for early Alzheimer's detection and personalized care.
In HealthTech
A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
Shares Neuroscience
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Healthcare
Biopharmaceutical company developing and commercializing CNS disease treatments.
Shares Biotechnology, Healthcare
Key facts
- Website
- cognitotx.com
- Headquarters
- Boston, Massachusetts, USA
- Founded
- 2011
- Total funding
- $213M (Series C)
- Business model
- B2B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 5 Mar 2026 | Series C | $105M | |
| 29 Jan 2024 | Series B Extension | $35M | |
| 22 Mar 2023 | Series B | $73M | FoundersX Ventures |
Tech stack
Detected on cognitotx.com, last scanned 2 Nov 2026. Run your own scan
- Analytics
- Google Tag Manager
- Support
- HubSpot
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Video / media
- Vimeo
Cognito Therapeutics scores 49. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Cognito Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Cognito Therapeutics is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Cognito Therapeutics raised?
Cognito Therapeutics has raised a total of $213M in funding. The most recent round on record is Series C.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Cognito Therapeutics


